http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2901702-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccfcb0fcd99dd1c3693b62fdafe85448
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4926
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
filingDate 2006-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2167660c365a33d757d2e0199eeba992
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb1cc4816a72fe2c50eee8b338c54739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55949ef976637ad0fb03eb5e3a50048d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a7a9dc3eb6e8c08741a2152f9a9e81d
publicationDate 2007-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2901702-A1
titleOfInvention USE OF GRANISETRON FOR THE TREATMENT OF ROSACEA SUBTYPES AND PHARMACEUTICAL COMPOSITIONS
abstract The invention relates to the use of granisetron or its salts as active principle in a pharmaceutical composition, more particularly dermatological. Preferably, the composition is applied topically. It is intended for the treatment and / or prevention of papulopapustous rosacea, phymatic rosacea and / or ocular rosacea.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2960152-A1
priorityDate 2006-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005058312-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005042194-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004171561-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6916487-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414864256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453283872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425823269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415755672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23689314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8314

Total number of triples: 35.